Toshio Takagi

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Robert J. Motzer, B. Yа. Alekseev, Sun Young Rha et al. · New England Journal of Medicine · 2021 · 1.8K citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate

Brian R. Lane, Sevag Demirjian, Ithaar Derweesh et al. · European Urology · 2015 · 212 citations

Medicine, Nephrology, Surgery +15

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

Robert J. Motzer, Camillo Porta, Masatoshi Eto et al. · Journal of Clinical Oncology · 2024 · 158 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Chronic Kidney Disease Due to Surgical Removal of Nephrons: Relative Rates of Progression and Survival

Sevag Demirjian, Brian R. Lane, Ithaar Derweesh et al. · The Journal of Urology · 2014 · 142 citations

Medicine, Surgery, Urology +13

A Phase II Study of Pazopanib in Patients with Localized Renal Cell Carcinoma to Optimize Preservation of Renal Parenchyma

Brian I. Rini, Elizabeth R. Plimack, Toshio Takagi et al. · The Journal of Urology · 2015 · 103 citations

Medicine, Oncology, Surgery +17